重组鸡α干扰素/白细胞介素-2融合蛋白体外活性评价方法研究

doi:10.16431/j.cnki.1671-7236.2015.12.007

›› 2015, Vol. 42 ›› Issue (12): 3153-3159.doi: 10.16431/j.cnki.1671-7236.2015.12.007

重组鸡α干扰素/白细胞介素-2融合蛋白体外活性评价方法研究

杨晓璐^1,2, 闫若潜², 李勤楠^1,2, 赵雪丽², 谢彩华², 刘梅芬², 张书阳^1,2

1. 河南科技大学动物科技学院, 洛阳 471003;
2. 河南省动物疫病预防控制中心, 郑州 450008

收稿日期:2015-04-17 出版日期:2015-12-20 发布日期:2015-12-30
通讯作者: 闫若潜 E-mail:yrq1688@126.com
作者简介:杨晓璐(1989-),女,河南开封人,硕士生,研究方向:预防兽医学,E-mail:yangxiaolu0410@163.com
基金资助:
河南省科技创新人才计划项目(豫科人组[2011]1号)

Study on the Activity Estimation Methods of Recombinant Chicken Interferon-α/Interleukin-2 Fusion Protein in vitro

YANG Xiao-lu^1,2, YAN Ruo-qian², LI Qin-nan^1,2, ZHAO Xue-li², XIE Cai-hua², LIU Mei-fen², ZHANG Shu-yang^1,2

1. College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, China;
2. Henan Centre for Animal Disease Control and Prevention, Zhengzhou 450008, China

Received:2015-04-17 Online:2015-12-20 Published:2015-12-30

摘要/Abstract

摘要： 为建立稳定、便捷的重组鸡α干扰素/白细胞介素-2融合蛋白(rChIFN-α-Linker-ChIL-2蛋白,重组融合蛋白)体外活性评价方法,本研究分别采用ChIFN-α和ChIL-2 ELISA方法检测重组融合蛋白与抗ChIFN-α单抗和抗ChIL-2单抗发生特异性免疫反应的活性;采用细胞病变抑制法检测重组融合蛋白在DF1细胞上抑制水疱性口炎病毒(VSV)和传染性法氏囊病病毒(IBDV)增殖活性;采用MTS法分别测定重组融合蛋白促鸡外周血T淋巴细胞(PBLC)和脾淋巴细胞增殖活性。结果表明,重组融合蛋白可以与抗ChIFN-α单抗和抗ChIL-2单抗发生特异性免疫反应;重组融合蛋白在DF1细胞上具有明显抗病毒活性,其抗VSV活性高于抗IBDV活性,且均明显高于rChIFN-α蛋白对照;不同浓度的重组融合蛋白均具有明显的促鸡PBLC和脾淋巴细胞增殖活性,且其促增殖活性明显高于rChIFN-α蛋白对照。本研究成功建立了重组融合蛋白体外活性检测评价方法,为进一步探究重组融合蛋白在鸡体内协同作用奠定基础。

关键词: 鸡α干扰素; 鸡白细胞介素-2; 重组融合蛋白; 体外活性

Abstract: In order to establish a stable,simple and rapid detection method to estimate the activities of the recombinant chicken interferon-α/interleukin-2 fusion protein (rChIFN-α-Linker-ChIL-2,recombinant fusion protein) in vitro,the activities of rChIFN-α-Linker-ChIL-2 were estimated by detecting its specific immune response to monoclonal antibody (MAb) against ChIFN-α and ChIL-2 by ELISA assay.The antiviral activities of rChIFN-α-Linker-ChIL-2 protein were tested by inhibiting the 50% appearance of cytopathic effect (CPE) of vesicular stomatitis virus (VSV) and infectious bursal disease virus (IBDV) on the passage cell lines DF1.The promoting proliferation activities of lymphocytes in the chicken peripheral blood and spleen of recombinant fusion protein were tested by MTS method.The results showed that rChIFN-α-Linker-ChIL-2 protein had the ability of specific immune response to anti-ChIFN-α MAb and anti-ChIL-2 MAb,respectively.The antiviral activity of rChIFN-α-Linker-ChIL-2 protein inhibiting the reproduction of VSV on DF1 cell line was higher than IBDV,and both of the antiviral activities of recombinant fusion protein against VSV and IBDV were much higher than the recombinant ChIFN-α protein (rChIFN-α) control.The recombinant fusion protein had apparent promoting proliferation activity of lymphocytes in the chicken peripheral blood and spleen,which were much higher than that of the rChIFN-α control.The study suggested that the activities detection and estimation methods of the recombinant fusion protein in vitro were successfully established,which laid the foundation for the further study of the synergy activity of recombinant fusion protein in vivo.

Key words: chicken interferon-α; chicken interleukin-2; recombinant fusion protein; in vitro activity

中图分类号:

S852.6

杨晓璐, 闫若潜, 李勤楠, 赵雪丽, 谢彩华, 刘梅芬, 张书阳. 重组鸡α干扰素/白细胞介素-2融合蛋白体外活性评价方法研究[J]. , 2015, 42(12): 3153-3159.

YANG Xiao-lu, YAN Ruo-qian, LI Qin-nan, ZHAO Xue-li, XIE Cai-hua, LIU Mei-fen, ZHANG Shu-yang. Study on the Activity Estimation Methods of Recombinant Chicken Interferon-α/Interleukin-2 Fusion Protein in vitro[J]. , 2015, 42(12): 3153-3159.

参考文献

[1] Meager A.Biological assays for interferons[J].Journal of Immunological Methods,2002,261(1/2):21-36.
[2] Johnson H M,Bazer F W,Szente B E,et al.How interferons fight disease[J].Scientific American,1994,270(5):68-75.
[3] Sekellick M J,Ferrandino A F,Hopkins D A,et al.Chicken interferon gene:Cloning,expression,and analysis[J].Journal of Interferon Research,1994,14:71-79.
[4] 程福亮,聂兆晶,陈甜甜,等.重组鸡α-干扰素的表达及其生物活性的初步研究[J].中国畜牧兽医,2014,41(11):35-39.
[5] 刘成倩,王静,李红,等.鸡干扰素-α基因原核表达载体的构建及高效表达[J].中国畜牧兽医,2014,41(4):47-50.
[6] Liao W J,Lin X,Leonard W J.Interleukin-2 at the crossroads of effector responses,tolerance,and immunotherapy[J].Immunity,2013,38(1):13-25.
[7] Taguchi T.Interleukin-2 (IL-2)[J].Gan To Kagaku Ryoho,1994,21(5):719-724.
[8] Robak T.Biological properties and therapeutic use of interleukin 2 (IL-2)[J].Postepy Higieny Medycyny Doswiadczalnej,1995,49(3):367-393.
[9] Prentice H G,Macdonald I D,Hamon M D.The role of immunotherapy in the treatment of acute myeloblastic leukemia:From allogeneic bone marrow transplantation to the application of interleukin 2[J].Cancer Treatment and Research,1993,64:121-134.
[10] 闫若潜,谢彩华,吴志明,等.鸡α干扰素/白细胞介素2基因的融合表达及活性研究[J].中国农业科学,2010,43(3):594-604.
[11] Zamoiskii E A.Evaluation of Reed-Muench method in determination of activity of biological preparations[J].Zhurnal Mikrobiology Epidemiology Immunobiology,1956,27(1):77-83.
[12] 闫若潜,吴志明,张志凌,等.猪α干扰素/白细胞介素2基因的融合表达及活性研究[J].畜牧兽医学报,2009,40(2):248-255.
[13] Legha S S.Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy[J].Semin Oncol,1997,24(1 Suppl 4):S39-S43.
[14] Lefèvre F,L'Haridon R,Borras-Cuesta F,et al.Production,purification and biological properties of an Escherichia coli-derived recombinant porcine alpha interferon[J].Clinical and Diagnostic Laboratory Immunology,1990,71(5):1057-1063.
[15] Oldham R R.Toxic effects of interferon[J].Science,1983,219(4587):902.

重组鸡α干扰素/白细胞介素-2融合蛋白体外活性评价方法研究

Study on the Activity Estimation Methods of Recombinant Chicken Interferon-α/Interleukin-2 Fusion Protein in vitro

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	杨晓璐, 闫若潜, 吴志明, 刘梅芬, 张代宝, 张书阳, 王淑娟, 赵雪丽, 刘毅. 重组鸡α干扰素/白细胞介素-2融合蛋白对鸡外周血T淋巴细胞亚群的影响研究[J]. , 2014, 41(11): 175-178.
[2]	于新友;赵蕾;王艳;沈志强;. 鸡白细胞介素-2分子生物学和疾病防治应用研究进展[J]. , 2011, 38(8): 81-84.